Media

The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations...
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and...

Press Releases

Mar 4 2004
WASHINGTON, D.C. (March 4, 2004) - Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement following House passage...
Feb 25 2004
NEW YORK (February 25, 2004) - More than 2,000 institutional and venture capital investors, business executives, industry analysts and media attended the BIO...
Feb 25 2004
NEW YORK (February 25, 2004) - Onyx Pharmaceuticals Inc. and Actelion Ltd. have won the 2004 James D. Watson Helix Awards. The winners, selected by peer vote...
Feb 24 2004
NEW YORK (February 24, 2004) - Genentech has won the 2004 James D. Watson Helix Award in the large-cap category and is being honored this afternoon at a BIO...
Feb 20 2004
WASHINGTON, D.C. (February 20, 2004) — Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement on today's...
Feb 19 2004
WASHINGTON, D.C. (February 19, 2004) - Executives representing more than 400 biotechnology and pharmaceutical companies from around the world will gather Feb....
Feb 19 2004
WASHINGTON, D.C. (February 19, 2004) - This year's BIO CEO & Investor Conference features 39 panel discussions, including a new series of Therapeutic...
Feb 17 2004
WASHINGTON, D.C. (February 17, 2004) — Executives and scientists from leading biotech and pharmaceutical companies will discuss "The Promise of Personalized...
Feb 12 2004
WASHINGTON, D.C. (February 12, 2004) — Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...